期刊档案 · 生物-遗传学
HEREDITAS
ISSN 0018-0661 · eISSN 1601-5223 · BioMed Central · DENMARK · Bimonthly · 创刊 2015
HEREDITAS 中科院 生物学 4区(2025 年升级版),影响因子 2.46,完全开放获取,APC 约 2,690 美元,近 24 个月 102 篇文章投稿到接收中位 115 天,录用比例容易(社区反馈),2025 年发文 259 篇,SCIE、Scopus 收录。
研究范围
研究范围与定位
HEREDITAS 由 BioMed Central 出版,属中科院生物学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Chromosomal and Genetic Variations、Botanical Research and Chemistry、Plant Reproductive Biology 等主题的论文,这 3 个主题约占 30.8%,主导子领域为 Plant Science、Ecology, Evolution, Behavior and Systematics。(根据 OpenAlex 主题统计与中科院分区数据生成)
• 发表涵盖遗传学和基因组学各个领域的研究 • 伦德孟德尔学会 官方期刊 • BMC是开放获取出版先行者,推动开放透明的科研传播 Springer Nature 致力于支持研究人员推动科学进展, 通过可信赖的期刊、严谨的编辑标准以及倡导开放性、科研诚信与研究影响力的全球学术社区, 助力研究成果被广泛传播与认可。
Hereditas is an open access, peer-reviewed journal, and the official publication of the Mendelian Society of Lund, dedicated to advancing genetics and genomics research across human and animal. Building on a century-long legacy in genetics, the journal publishes high-quality research spanning fundamental discoveries, evolutionary insights, and applied studies that impact medicine and biotechnology. We welcome submissions that shed light on inheritance, genetic diversity, molecular mechanisms, and application of genome-scale technologies. Areas of Interest 1. Medical and clinical genetics Studies of genetic and epigenetic alterations underlying human disease, including cancer genetics, hereditary syndromes, pharmacogenomics, and diagnostic or prognostic applications of genomics. This area emphasizes clinically relevant discoveries that advance diagnosis, risk stratification, and patient management. 2. Regulatory genomics and non-coding RNAs Investigations into non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, as well as other regulatory elements that govern gene expression in health, and human diseases. These studies advance understanding of complex regulatory networks at the genomic level. 3. Genomic technologies and data science Research employing high-throughput sequencing, genome-wide association studies, functional and population genomics, integrative multi-omics, and bioinformatics approaches to explore genetic diversity in human diseases. Computational predictions and models need to be confirmed with experimental validation performed in vitro or in vivo to ensure biological relevance. 4. Gene therapy and genomic medicine Studies on gene-based therapeutic interventions, including CRISPR technologies, RNA-based therapies, delivery systems, and clinical applications of gene editing. This theme reflects the transition from genetic diagnosis to treatment of human diseases for personalized medicine. 5. Plant genetics and genomics Studies on genetic and epigenetic mechanisms underlying plant development, adaptation, and evolution, including molecular and classical genetics, cytogenetics, population genomics, and genome organization in wild and cultivated species. This scope includes research on plant domestication, breeding, stress responses, and genetic diversity, with relevance to agriculture, biodiversity, and environmental change.
摘自期刊官网 Aims & Scope
研究方向(LetPub):生物-遗传学
主编 Ramin Massoumi出版商官网
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Chromosomal and Genetic VariationsAgricultural and Biological Sciences12.4%
- Botanical Research and ChemistryAgricultural and Biological Sciences11.6%
- Plant Reproductive BiologyBiochemistry, Genetics and Molecular Biology6.8%
- Wheat and Barley Genetics and PathologyAgricultural and Biological Sciences6.4%
- Genetic diversity and population structureBiochemistry, Genetics and Molecular Biology6.4%
- Plant and animal studiesAgricultural and Biological Sciences6%
- Genetic Mapping and Diversity in Plants and AnimalsBiochemistry, Genetics and Molecular Biology4.6%
- Plant Taxonomy and PhylogeneticsAgricultural and Biological Sciences4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)生物学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 生物学 | 4 区 |
| 小类 | 遗传学GENETICS & HEREDITY | 4 区 |
Top 期刊:否综述期刊:否
《新锐期刊分区表》( 2026年3月发布)生物学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 生物学 | 3 区 |
| 小类 | 遗传学GENETICS & HEREDITY | 3 区 |
Top 期刊:否综述期刊:未标注
期刊分区表( 2023年12月旧的升级版)生物学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 生物学 | 3 区 |
| 小类 | 遗传学GENETICS & HEREDITY | 4 区 |
Top 期刊:否综述期刊:否
数据库收录
SCIEScopusDOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
期刊官网自述收录
MEDLINEEmbaseCASCAB Abstracts出版商官网
其他:Google Scholar、ProQuest、Dimensions、CNKI、Baidu、AGRICOLA、Naver、OCLC、Portico、CLOCKSS
期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 2.46LetPub ·
- 影响因子(出版商公布) 2025
- 2.6出版商官网 ·
- 五年影响因子(出版商公布) 2025
- 2.7出版商官网 ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 45LetPub ·
- h-index
- 112OpenAlex ·
- i10-index
- 3,039OpenAlex ·
- 两年平均被引
- 2.01OpenAlex ·
- 自引率
- 7.7%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 251LetPub ·
- 年下载量(出版商公布) 2025
- 536,500出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 6,311 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 112 | 112 | 46 |
| 2025 | 259 | 259 | 569 |
| 2024 | 57 | 57 | 244 |
| 2023 | 39 | 39 | 339 |
| 2022 | 47 | 47 | 503 |
| 2021 | 48 | 48 | 674 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
115 天投稿到接收中位数 · P25–P75 79 天 – 156 天
- 接收到上线
- 中位数 14 天(102 篇)
- 投稿到上线
- 中位数 140 天
- 样本
- 102 篇有投稿与接收日期的文章(窗口内共 369 篇),最近一篇接收于
只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度(社区反馈)
- >12周,或约稿LetPub ·
- 平均录用比例(社区反馈)
- 容易LetPub ·
- 投稿到首次决定
- 5 天出版商官网 ·
- 投稿到发表(期刊自报)
- 约 6 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,通常向作者收取文章处理费(APC)。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | EUR 2,290 / USD 2,690 / GBP 1,990 | 有 | CC BY、CC0 | |
| OpenAlex | USD 2,590 / EUR 2,190 / GBP 1,890 | — | — | |
| LetPub | GBP 1,790 / USD 2,490 / EUR 2,090 | 有 | — | |
| 出版商官网 | GBP 1,990 / USD 2,690 / EUR 229 / EUR 2,290 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
接收的文章类型8 种
- brief reportResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- commentaryResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- letter to the editorResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- meeting reportResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- opinionResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- researchResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- reviewResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
- softwareResearch Brief report Software Review Opinion Commentary Letter to the Editor Meeting Report未说明篇幅
官网政策摘录作者资格、数据可用性、许可与版权、开放获取、同行评审
- 作者资格
Manuscripts may only be submitted by an author, not a third party 模型摘要
Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
原文 ↗出版商官网 ·- 数据可用性 Formatting the 'Availability of data and materials' section of your manuscript
CC0 1.0 Public Domain Dedication waiver applies to all published data 模型摘要
The following format for the 'Availability of data and materials section of your manuscript should be used:
原文 ↗出版商官网 ·- 许可与版权 Licensing and copyright
Creative Commons Attribution 4.0 International (CC BY) licence for articles 模型摘要
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Hereditas articles are published open access under a CC BY (Creative Commons Attribution 4.0 International l…
原文 ↗出版商官网 ·- 开放获取 Benefits of open access
APC waivers/discounts for corresponding authors in the world's lowest income countries 模型摘要
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
原文 ↗出版商官网 ·- 同行评审 Peer review policy
Authors may suggest peer reviewers with institutional email addresses or identifiers (ORCID/Scopus ID) 模型摘要
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- BioMed Central
- 出版国家或地区
- DENMARK
- 出版语言
- English
- 出版周期
- Bimonthly
- 创刊年份
- 2015
- ISSN
- 0018-0661
- 电子版 ISSN
- 1601-5223
- 学会 / 主办单位
- Mendelian Society of Lund
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 HEREDITAS 的常见问题
HEREDITAS 是中科院几区期刊?
2025 年升级版分区表中,HEREDITAS 为生物学 4区,小类 遗传学 4 区。2026 年新锐版分区表中为生物学 3区。不同版本与大小类分区不能混用。
HEREDITAS 的影响因子是多少?
LetPub 汇总的最新公布影响因子为 2.46,CiteScore 为 2.3,h-index 为 112。
HEREDITAS 的审稿周期多长?
按 2024年10月至2026年10月(近 24 个月)102 篇已发表文章登记的日期,投稿到接收的中位数为 115 天(四分位 79–156 天);投稿社区反馈的平均审稿速度为超过 12 周,平均录用比例反馈为“容易”。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
HEREDITAS 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,HEREDITAS 被 SCIE、Scopus、DOAJ 收录。期刊官网自述还被 MEDLINE、Embase、CAS、CAB Abstracts 收录,该清单未与各数据库逐一核对。
HEREDITAS 是开放获取期刊吗?版面费多少?
HEREDITAS 为完全开放获取。APC 约 2,690 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。